Status - Institut für angewandte Erkenntnistheorie und medizinische

IFAEMM e. V. Modellprojekt Anthroposophische Medizin: Abschlussbericht Seite 517 von 534
530. Metson RB, Gliklich RE. Clinical outcomes in patients with chronic sinusitis. Laryngoscope
2000;110(3 Pt 3):24-28.
531. Michel P, Dartigues JF, Lindoulsi A, Henry P. Loss of productivity and quality of life in migraine
sufferers among French workers: results from the GAZEL cohort. Headache 1997;37(2):71-78.
532. Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P. Bone mineral density
in women with depression. N Engl J Med 1996;335(16):1176-1181.
533. Middleton H, Shaw I. Distinguishing mental illness in primary care. We need to separate proper
syndromes from generalised distress. BMJ 2000;320(7247):1420-1421.
534. Milgrom C, Finestone A, Lev B, Wiener M, Floman Y. Overexertional lumbar and thoracic back pain
among recruits: a prospective study of risk factors and treatment regimens. J Spinal Disord
1993;6(3):187-193.
535. Milhous RL, Haugh LD, Frymoyer JW, Ruess JM, Gallagher RM, Wilder DG, Callas PW. Determinants
of vocational disability in patients with low back pain. Arch Phys Med Rehabil
1989;70(8):589-593.
536. Miller NS, Gold MS. Benzodiazepines: a major problem. Introduction. J Subst Abuse Treat
1991;8(1-2):3-7.
537. Milne S, Welch V, Brosseau L, Saginur M, Shea B, Tugwell P, Wells G. Transcutaneous electrical
nerve stimulation (TENS) for chronic low back pain. Cochrane Database Syst Rev
2001;(2):CD003008
538. Min YG, Jung HW, Kim HS, Park SK, Yoo KY. Prevalence and risk factors of chronic sinusitis in
Korea: results of a nationwide survey. Eur Arch Otorhinolaryngol 1996;253(7):435-439.
539. Momsen U. Das unruhige Kind. Diagnostische und therapeutische Ansätze, Falldarstellungen
unter Einbezug Anthropsoophischer Kunsttherapie. Der Merkurstab 2002;55(Sonderheft
IV):S72-S77.
540. Momsen U. Leserbrief: Zum Artikel von Walter Pohl: "Das Aufmerksamkeitsdefizitsyndrom menschenkundlich
betrachtet" Heft 4/2002. Der Merkurstab 2003;56(1):38-38.
541. Moncrieff J, Wessely S, Hardy R. Antidepressants using active placebos. Cochrane Database Syst
Rev 2001;(2):CD003012
542. Monzon MJ, Lainez MJ. Quality of life in migraine and chronic daily headache patients. Cephalalgia
1998;18(9):638-643.
543. Morris P, Leach A. Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane
Database Syst Rev 2002;(4):CD001094
544. Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures
and independent-groups designs. Psychol Methods 2002;7(1):105-125.
545. Mouland G, Bratland B, Fagan M, Malde K, Rygh E, Welander F, Waerdahl E, Ytterdahl T. Bruk av
nye antidepressiva i allmenpraksis. Tidsskr Nor Laegeforen 1998;118(29):4497-4500.
546. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity
disorder. Arch Gen Psychiatry 1999;56(12):1073-1086.
547. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity
disorder. Arch Gen Psychiatry 1999;56(12):1088-1096.
548. Muhlig S, Petermann F, Bergmann KC. Verbreitung der Non-Compliance bei Asthma-Patienten:
Aktueller Forschungsstand und methodologische Probleme. Pneumologie 2001;55(4):163-176.
549. Mulrow CD, Williams JW, Jr., Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, Stamm K.
Efficacy of newer medications for treating depression in primary care patients. Am J Med
2000;108(1):54-64.
550. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden
of Disease Study. Lancet 1997;349(9063):1436-1442.
551. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life
expectancy: global Burden of Disease Study. Lancet 1997;349(9062):1347-1352.